Publicly funded, pegylated interferon-alpha treatment in British Columbia: Disparities in treatment patterns for people with hepatitis C

BACKGROUND: An estimated 60,000 British Columbians are chronically infected with the hepatitis C virus (HCV); 10% to 20% will develop cirrhosis after 20 years and 5% to 10% of these will develop hepatocellular carcinoma. Although treatment may prevent cirrhosis and liver cancer, and improve quality...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hsu, Priscilla C, Buxton, Jane A, Tu, Andrew W, Hill, Warren D, Yu, Amanda, Krajden, Mel
Médium: Artigo
Jazyk:Inglês
Vydáno: Pulsus Group Inc 2008
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2662892/
https://ncbi.nlm.nih.gov/pubmed/18414709
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky